1) ascetic fluid-type hepatocarcinoma H22 model
腹水型H22肝癌模型
2) ascitic fluid-type hepatocarcinoma H_(22) model
腹水型肝癌H22模型
3) H22 ascites hepatoma
H22腹水型肝癌
4) ascites H22 hepatoma
腹水型肝癌细胞H22
1.
The Q-TRAP LC/MS/MS System was employed to determine the average molecular weight of chitooligosaccharides and study the inhibitive effect of chitooligosaccharides and bifidobacterium on ascites H22 hepatoma.
采用过氧化氢氧化法制备水溶性壳寡糖,采用Q TRAP LC/MS/MS System测定壳寡糖的平均分子量,观察壳寡糖和双歧杆菌对腹水型肝癌细胞H22的抑制作用。
5) H22 liver cancer ascites lump
H22肝癌腹水瘤
6) bearing intraperitoneal H22 tumor
腹水型肝癌
1.
Objective To investigate the mechanism of Secretio bufonis injection on the carcinostatic activities in mice bearing intraperitoneal H22 tumor.
目的探讨蟾酥注射液对H22腹水型肝癌小鼠肿瘤抑制作用的作用机理。
补充资料：混合型肝癌
混合型肝癌
又称"混合细胞型肝癌"。原发性肝癌的一个组织学类型，较少见，具有 *肝细胞癌及*胆管上皮细胞癌两种结构。参见"原发性肝癌"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条